Loading clinical trials...
Loading clinical trials...
This is a Phase 2 multicenter, randomized, double-blind, placebo controlled study of ATR-101 to evaluate the efficacy and safety of orally-administered ATR-101 in adults with endogenous Cushing's synd...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Millendo Therapeutics US, Inc.
NCT06573723 · Rare Diseases, Amyloidosis, and more
NCT06962202 · Cushing Syndrome
NCT05521529 · Cushing Syndrome
NCT05881005 · Cushing Syndrome, Fatty Liver Disease
NCT04890444 · Cushing Syndrome, Aldosteronism, and more
Massachusetts General Hospital
Boston, Massachusetts
The Cleveland Clinic Foundation
Cleveland, Ohio
Medical College of Wisconsin
Milwaukee, Wisconsin
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions